Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 37.41MCash and Equivalents
VS
Market
Sector
Industry
History
$ 4.41Close
$ 2.88 - $ 4.9 52-Week Range
Ticker Information
Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQARBUTUS BIOPHARMA CORP - Cash and Equivalents Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABUS - CashnEq Historical data
| Date | Cash and Equivalents |
|---|---|
| 6/30/2025 | $ 37.41M |
| 3/31/2025 | $ 37.08M |
| 12/31/2024 | $ 36.33M |
| 9/30/2024 | $ 31.85M |
| 6/30/2024 | $ 62.79M |
| 3/31/2024 | $ 43.1M |
| 12/31/2023 | $ 26.29M |
| 9/30/2023 | $ 17.53M |
| 6/30/2023 | $ 27.2M |
| 3/31/2023 | $ 40.57M |
Key Performance Insights, Last 5 Years
- ARBUTUS BIOPHARMA CORP's latest trailing twelve months (TTM) CashnEq stands at $ 96.92M.
- Over the past 5 years, ARBUTUS BIOPHARMA CORP's average CashnEq has been $ 49.51M.
- The median CashnEq for ARBUTUS BIOPHARMA CORP during this period was $ 38.99M
- ARBUTUS BIOPHARMA CORP reached its highest CashnEq over the past 5 years at $ 109.28M.
- The lowest CashnEq recorded by ARBUTUS BIOPHARMA CORP in the same timeframe $ 17.53M
ARBUTUS BIOPHARMA CORP's CashnEq vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq Benchmarks
Similar metrics to CashnEq:
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Net Cash Flow - Change in Cash & Cash Equivalents - [Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]
- Non-Current Assets - [Balance Sheet] The non-current (long-term) portion of [Assets] that are not easily converted to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Cash Ratio - [Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
Definition of Cash and Equivalents
[Balance Sheet] Cash and cash equivalents are the sum of [Assets] that are cash or can be converted to cash in less than one year.ABUS - Cash and Equivalents, Last 5 years
$ 17.53M
Minimum
Sep 30, 2023
$ 109.28M
Maximum
Dec 31, 2021
$ 49.51M
Average
$ 38.99M
Median
CashnEq Benchmark AnalysisMarket
The chart above depicts the distribution of CashnEq for companies in the Total Stock Market. The average CashnEq of the companies is $ 98.87M with a standard deviation of $ 119.34M.
The following table provides additional summary stats:
CashnEq in the Market:
| filtered constituents | 3.61K |
|---|---|
| min | $ 0 |
| max | $ 492.42M |
| average | $ 98.87M |
| median | $ 48.02M |
| std | $ 119.34M |